FIGURE 4.

(A) PFS of AFP negative group and AFP positive group after 1 month operation. (B) PFS of PIVKA‐II negative group and PIVKA‐II positive group after 1month operation. (C) Serial AFP changes in 6 patients who responded to treatment after TACE and at the time of HCC relapse. (D) Serial PIVKA‐II changes in 6 patients who responded to treatment after TACE and at the time of HCC relapse. AFP, alpha‐fetoprotein; HCC, hepatocellular carcinoma; PFS, progression‐free survival; PIVKA‐II, prothrombin induced by vitamin K absence II